Is It Too Late To Consider Thermo Fisher Scientific (TMO) After Recent Share Price Weakness?

Endpoints NewsPost-Hoc Live: Jeremy Levin on biotech's existential moment

Endpoints NewsOutlook says FDA will sign off on its version of Avastin for wet AMD

BioPharma DiveEarly data for heart drug affirm Lilly’s billion-dollar bet on Verve

BioPharma DiveLilly dives into vaccine research with 3 biotech buyouts

FierceBiotechMakary’s FDA reforms ‘continue to move forward’ despite leadership turmoil

Clinical OMICsGPS Tracking Upends Rural Uganda’s Schistosomiasis Transmission Assumptions

Endpoints NewsCartesian secures funding to 'accelerate' launch; Editas sells $125M in stock

Endpoints NewsCan AI do scientific research? Billions chase hopes of superintelligence

BioWorldLilly buys three vaccine makers; PCSK9 base editor shows promise

BioWorldChina’s new IIT rules expected to wipe out ‘gray market’

BioWorldDaewoong takes over Turn Bio’s longevity platform from Hanall

BioWorldTennor’s $80M Hong Kong IPO to fund antibacterial drug pipeline